Alpha Tau Medical (DRTSW) Depreciation & Amortization (CF) (2021 - 2022)

Alpha Tau Medical (DRTSW) posted Depreciation & Amortization (CF) of $244000.0 for Q2 2022, up 5.63% sequentially from $231000.0 in Q1 2022.

Alpha Tau Medical (DRTSW) Depreciation & Amortization (CF) (2021 - 2022) Analysis & Trends

Alpha Tau Medical has reported Depreciation & Amortization (CF) for 2 years, with the latest figure at $244000.0 in Q2 2022.

Quarterly Depreciation & Amortization (CF) changed N/A year-over-year to $244000.0 in Q2 2022, while the trailing twelve-month figure through Mar 2023 was $244000.0 (up 5.63% YoY) and the FY2025 annual result came in at $1.2 million, up 11.8% from the prior year.
Depreciation & Amortization (CF) climbed to $244000.0 in Q2 2022 per DRTSW's latest filing, from $231000.0 in the prior quarter.
Over five years, Depreciation & Amortization (CF) peaked at $244000.0 in Q2 2022 and troughed at $164000.0 in Q1 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Depreciation & Amortization (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	56.50 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	123.70 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	40.52 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	191.83 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Alpha Tau Medical	383.00 Mn	200.58 Mn	-	-

Download Data